Bemdaneprocel is a cell therapy composed of human embryonic stem cell-derived midbrain dopaminergic neuron progenitor cells
The post AAN 2026: BlueRock reports positive safety data for bemdaneprocel in Parkinson’s appeared first on Clinical Trials Arena.